Sugi Predict

Sugi Predict / Compounds / SCHEMBL4869798

SCHEMBL4869798

SCHEMBL4869798

O=C(Nc1cccc(O)c1)N1CCCCc2ccccc21

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.69
▸ MEN1 O00255 2/20 0.69
▸ KMT2A Q03164 2/20 0.69
▸ ALDH1A1 P00352 1/20 0.67
▸ MAPK1 P28482 1/20 0.67
▸ L3MBTL1 Q9Y468 1/20 0.67
▸ ATM Q13315 1/20 0.65
▸ TP53 P04637 3/20 0.61
▸ NPC1 O15118 2/20 0.61
▸ PKM P14618 2/20 0.61
▸ NFKB1 P19838 2/20 0.61
▸ RAB9A P51151 2/20 0.61
▸ NFKB2 Q00653 2/20 0.61
▸ RELA Q04206 2/20 0.61
▸ SMN1; SMN2 Q16637 2/20 0.61
▸ HTT P42858 1/20 0.61
▸ MAPT P10636 2/20 0.58
▸ POLB P06746 2/20 0.56
▸ THRB P10828 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4867471 0.87 TP53 (0.81) LMNAMEN1KMT2AALDH1A1MAPK1
SCHEMBL14089574 0.86 LMNA (0.71) LMNAMEN1KMT2AALDH1A1MAPK1
SCHEMBL4863845 0.86 MEN1 (0.67) LMNAMEN1KMT2AALDH1A1MAPK1
SCHEMBL4863076 0.86 MAPT (0.69) LMNAMEN1KMT2ATP53NPC1
SCHEMBL4869023 0.85 TP53 (0.78) LMNAMEN1KMT2AALDH1A1MAPK1
SCHEMBL4871151 0.85 MAPT (0.67) LMNAMEN1KMT2ATP53NPC1
SCHEMBL4866075 0.84 TP53 (0.59) LMNAMEN1KMT2AALDH1A1MAPK1
SCHEMBL4870796 0.84 TP53 (0.59) LMNAMEN1KMT2AALDH1A1MAPK1
Hydrochloric Acid SCHEMBL4863741 0.83 MEN1 (0.59) LMNAMEN1KMT2AALDH1A1MAPK1
SCHEMBL4871956 0.82 ALDH1A1 (0.67) LMNAMEN1KMT2AALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7368444-B2 N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-06 — — US claimed
US-7368444-B2 N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-06 — — US disclosed
US-20050101600-A1 N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 — — US disclosed
EP-1475368-A1 N-CARBAMOYL NITROGEN-CONTAINING FUSED RING COMPOUNDS AND DRUGS CONTAINING THESE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2004-11-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050101600-A1 N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient CNR1, CNR2, NPSR1 LMNA 2162/4885MEN1 651/4885KMT2A 2577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.